The lame duck session of Congress hurtles toward its impending conclusion. Three important bills remain in play — the National Defense Authorization Act, the 21st Century Cures Act, and the resolution continuing funding for the federal government. The House has passed the first two bills and the Senate is expected to act on them today or tomorrow. The House leadership unveiled the new continuing resolution last evening.
- Here’s the Wall Street Journal’s latest report on the NDAA.
- The Boston Globe’s STAT provides an overview of the Cures Act under the guise of listing winners and losers.
- The Hill reports on the proposed continuing resolution which would fund the federal government through April 28, 2017.
- The New York Times Upshot blog discusses an obvious flaw in the Affordable Care Act — one size fits all healthcare.
- The Drug Channels blog uses a recent prescription drug manufacturer announcement to again illustrate the fundamental flaws in that market.
- The FEHBlog noticed this Aspire Health press release which provides details on the current geographic scope of its services.